In suspended CLL cells, ATO significantly diminished the expression of Mcl-1 and Bfl-1 (anti-apoptotic) and upregulated Bim and Noxa (pro-apoptotic), compared to control cells (Figure 4A). The gene discussed is BCL2L11; the disease is B-cell chronic lymphocytic leukemia.